The Milne Institute for Healthcare Innovation
The Milne Institute for Healthcare Innovation is the result of a generous donation from George and Carol Milne. “As a scientist and a biomedical researcher with a broad interest in outcomes, it is clear that Gaylord fills a unique niche that is not well-represented in our country – patients recovering from devastating injuries or illnesses,” said George Milne, Jr., PhD, retired Executive Vice President of Global Research and Development and President of Central Research at Pfizer, Inc.
Housed on the Gaylord campus in Wallingford, Connecticut, the Milne Institute conducts research and develops evidence-based practices and applied technologies, which have the potential to change lives around the world, by leveraging Gaylord’s expertise in the care of brain and spinal cord injuries, complex strokes, amputations, and pulmonary diseases.
The Institute provides a collaborative, multidisciplinary environment for dedicated researchers to work with Gaylord's team of clinicians while partnering with corporations and foundations to conduct and disseminate data-driven research. All research and corporate partnerships are part of the Institute including two cross-pollinating centers: The Center for Research and Innovation and The Center for Applied Technologies.
“The national need for a resource that can effect profound outcomes for people of all ages is extraordinary. Not only will we have the ability to perform transformational research on cutting-edge technologies, but also research some of the more modest things that, in the end, can have an enormous impact on helping patients thrive.” George Milne, Jr., PhD
Milne Institute Leadership
The Milne Institute is led by Executive Director Peter Grevelding, PT, MSPT, NCS, and Medical Director, David Rosenblum, MD, a Gaylord physiatrist with nearly 30 years of research experience, including conducting research with the Spinal Cord Injury (SCI) Model System.
Peter Grevelding, Executive Director